APA (7th ed.) Citation

Li, G., Lin, S., Yu, Z., Wu, X., Liu, J., Tu, G., . . . Wu, L. (2022). A PARP1 PROTAC as a novel strategy against PARP inhibitor resistance via promotion of ferroptosis in p53-positive breast cancer. Biochemical pharmacology, 206, 115329. https://doi.org/10.1016/j.bcp.2022.115329

Chicago Style (17th ed.) Citation

Li, Ge, et al. "A PARP1 PROTAC as a Novel Strategy Against PARP Inhibitor Resistance via Promotion of Ferroptosis in P53-positive Breast Cancer." Biochemical Pharmacology 206 (2022): 115329. https://doi.org/10.1016/j.bcp.2022.115329.

MLA (9th ed.) Citation

Li, Ge, et al. "A PARP1 PROTAC as a Novel Strategy Against PARP Inhibitor Resistance via Promotion of Ferroptosis in P53-positive Breast Cancer." Biochemical Pharmacology, vol. 206, 2022, p. 115329, https://doi.org/10.1016/j.bcp.2022.115329.